BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations
Clinical trial NCT06032936 · TERMINATED
Trial details
- NCT number
- NCT06032936
- Sponsor
- LianBio LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-27
- Primary completion
- 2024-03-29
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.